Oxford Immunotec Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 01, 2016 12:00 pm UTC| Business
Fourth quarter revenue of$16.8 millionincreased 42% on a constant currency basis compared to prior year period2015 revenue of $62.8 million increased 33% on a constant currency basis compared to prior yearT-SPOT®.PRT assay...
Mar 01, 2016 12:00 pm UTC| Business
LEIDEN, the Netherlands, March 01, 2016 -- ProQR Therapeutics N.V.(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe orphan diseases...
PRGX Global, Inc. Announces Fourth Quarter and Full Year 2015 Financial Results
Mar 01, 2016 12:00 pm UTC| Business
ATLANTA, March 01, 2016 -- PRGX Global, Inc. (Nasdaq:PRGX), a global leader in Recovery Audit and Spend Analytics services, today announced its unaudited financial results for the fourth quarter and twelve months ended...
NGL Media and John Leguizamo Launch Full-Scale Production Division, NGL Studios
Mar 01, 2016 12:00 pm UTC| Business
NEW YORK, March 01, 2016 -- NGL Media, the leading Latino video marketing solutions company co-founded by CEO, David Chitel, and actor John Leguizamo, is expanding its operations around a newly branded full-scale...
Mar 01, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 01, 2016 -- Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) today announced that Barry Selick, Ph.D., Threshold’s Chief Executive Officer, will present a company overview at the Cowen...
Mitek Signs Mobile Deposit® Agreement With Top Five U.S. Bank for Business Multi-Check Capture
Mar 01, 2016 12:00 pm UTC| Business
SAN DIEGO, March 01, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com) a global leader in mobile capture and identity verification software solutions, today announced that a top five U.S. bank has selected its Mobile...
Curis to Present at the Cowen and Company 36th Annual Health Care Conference
Mar 01, 2016 12:00 pm UTC| Business
LEXINGTON, Mass., March 01, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced...